Sanofi_Web_Banner.jpg

Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. We help people with debilitating and complex conditions that are often difficult to diagnose and treat. Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.

 

We strive to transform the rare blood disorder landscape by boldly reimagining treatment expectations through disruptive science and a patient-first approach. Our portfolio of products and innovative pipeline of early- to late-stage clinical development therapies focus on addressing persistent unmet patient needs through breakthrough technologies, including siRNA and BTK inhibitors. Inspired by patients and driven by science, we are focused on helping to make a transformative difference in the standard of care for people affected by rare blood disorders around the world.  Learn more at www.sanofi.com.

 

Save the dates to join the below Symposium and Presentation Theater sessions and please visit our Medical and Commercial virtual booths to learn more about what Sanofi Genzyme Rare Blood Disorders has to offer.  Access will be available starting July 11 with a valid ISTH2021 Registration. 

Jon Doe

ISTH_Rilza_Symposium Flyer_Final.png

Challenges & Emerging Therapies in the Management of ITP
 

with Dr Ghanima & Dr Cooper

 

Sunday July 18
12:30-13:30 EST
For HCPs Only

Jane Doe

Session 2 PT 19 July 0700.jpg

From Insights to Outcomes in Hemophilia B
 

with Dr Sidonio, Dr Shapiro & Dr Hermans
 


Monday July 19
7:00-7:45 EST
For HCPs Only

James Doe

Session 3 LS 19 July 1230.jpg

Elevating Expectations for Factor Replacement to go Beyond Current
 

with Dr Tarantino, Dr Astermark, Dr Hart & Dr Konkle 

Monday July 19
12:30-13:30 EST  
For HCPs Only

5-25 MAT-GLB-2102121_Cablivi Global_Save

Evolving Care in aTTP – New Treatment Perspectives

with Dr Cataland, Dr Coppo, Dr Brinkotter & Dr Scully

 

Tuesday July 20
7:00-7:45 EST
For HCPs Only

61824_Sanofi_ISTH_SideTowerBanner_24May2

What Are We Monitoring in Hemophilia?

with Prof. Lenting, Dr Young & Dr Arruda

 


Tuesday July 20 
12:30- 13:30 EST

For HCPs Only

BOOTHS

Sanofi Genzyme Rare Blood Disorders

Commercial Exhibitor Booth

Sanofi Genzyme Rare Blood Disorders

Medical Exhibitor Booth

For HCPs Only

MAT-GLB-2102209 May 2021